Dosieâ„¢ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction
Cancers, May 2023 (Special Issue: Remote-Controlled Therapeutics for Cancer Therapy and Imaging) – Currently, there are no effective...
Dosieâ„¢ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction
Dosieâ„¢ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma
Simphotek partners with Penn in fighting Mesothelioma
Simphotek announces selection as a MedTech company
Dosieâ„¢ adds modeling Interstitial Photodynamic Therapy (I-PDT)
Dosieâ„¢ modeling software predicts better PDT outcomes.
Treatment planning and real-time dosimetry for I-PDT
Simphotek advances treatment of cancer using light-drug interacitons
Simphotek accelerates PDT entry into the era of personalized medicine
State Resources Help Newark-based Simphotek Aid World’s Leading Cancer Centers